| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.22T | — |
| Operating expense | — | — |
| Net income | 113.20B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TKDA.F returned +24.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +19.8% |
| 1 year | +24.9% |
| 5 years | +41.9% |
| All-time high | €18.50 (Nov 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in TKDA.F would be worth today ›Yes. Takeda Pharmaceutical Company Limited paid 2 dividends over the past 12 months. The most recent was €0.26 per share on Mar 31, 2026. The dividend yield is 3.52%.
Takeda Pharmaceutical Company Limited is part of the Healthcare sector.
Takeda Pharmaceutical Company Limited has a market cap of 49.50B EUR, based on the latest quote.
Takeda Pharmaceutical Company Limited is scheduled to report earnings on Oct 29, 2026.
